Skip to main content
Fig. 2 | BMC Women's Health

Fig. 2

From: The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis

Fig. 2

Pooled HRs for progression-free survival A and overall survival B by residual disease status. *Random effects. †Fixed effects. Residual disease > 1 cm category includes studies reporting residual disease 1–2 cm and residual disease > 1 cm. All comparisons were considered significant (p < 0.05). CI, confidence interval; HR, hazard ratio

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us